It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
It works 100% of the time to eradicate cancer completely, and cancer does not recur even years later. That is how researchers describe the most convincing cancer cure ever announced.
Normal Gc protein (also called Vitamin-D binding protein) , an abundant glyco-protein found in human blood serum, becomes the molecular switch to activate macrophages when it is converted to its active form, called Gc macrophage activating factor (Gc-MAF). Gc protein is normally activated by conversion to Gc-MAF with the help of the B and T cells (bone marrow-made and thymus gland-made white blood cells). But, as researchers explain it themselves, cancer cells secrete an enzyme known as alpha-N-acetylgalactosaminidase (also called Nagalase) that completely blocks conversion of Gc protein to Gc-MAF, preventing tumor-cell killing by the macrophages. This is the way cancer cells escape detection and destruction, by disengaging the human immune system. This also leaves cancer patients prone to infections and many then succumb to pneumonia or other infections.
The once-weekly injection of minute amounts of Gc-MAF, just 100 nanograms (billionths of a gram), activates macrophages and allows the immune system to pursue cancer cells with vigor, sufficient to produce total long-term cures in humans.
The National Cancer Institute estimates cancer care in the U.S. costs ~$72 billion annually (2004). Furthermore, about $55 billion of cancer drugs are used annually, none which have not significantly improved survival rates throughout the history of their use. If a typical cancer patient had to undergo 30 GcMAF injections at a cost of $150 per injection, that would cost ~$4500, not counting doctor’s office visits and follow-up testing. For comparison, gene-targeted cancer drugs range from $13,000 to $100,000 in cost per year and produce only marginal improvements in survival (weeks to months). [Targeted Oncology 2007 April, 2 (2); 113-19]
Up to this point, the National Cancer Institute is totally silent on this discovery and there is no evidence the cancer care industry plans to quickly mobilize to use this otherwise harmless treatment.
Known more commonly as “Deca,” deca durabolin is an injectable steroid with a long and relatively positive history. It has been used to effectively treat HIV+ and AIDS and is known as a phenomenal steroid for building muscle mass. Deca Durabolin is often used in combination with other steroids such as Tren — this is made possible by the use of Dostinex which allows these two anabolics to be used together [even at the same time] without worries about hormones such as testosterone getting thrown way off balance.
Nandrolone Decanoate, aka “Deca Durabolin” is the brand name for the Organon produced product, first made available in the early 80’s. “Deca” is therefore just a brand name, although currently, the black market slang is to call any Nandrolone product with the Decanoate ester “Deca.” It’s a progestin, made by removing the carbon atom at the 19th position of the steran nucleus.
Originally posted by Rubinstein
There are already many Cancer cures, though we just don't hear about them, unless Big Phama has a patent. The Cancer industry is worth $Trillions, so it's fiercely protected.edit on 2-5-2012 by Rubinstein because: (no reason given)
But the beauty of using your own immune system to attack cancer is that it remembers how to defeat it for the rest of your life: it doesn't come back. And unlike chemotherapy, the side effects are trivial.